Lifevantage Price to Book Ratio 2012-2026 | LFVN
Historical price to book ratio values for Lifevantage (LFVN) over the last 10 years. The current price to book ratio for Lifevantage as of June 17, 2026 is 1.60.
| Lifevantage Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-06-17 | 6.06 | 0.00 | |
| 2026-03-31 | 4.29 | 0.00 | |
| 2025-12-31 | 6.06 | 0.00 | |
| 2025-09-30 | 9.51 | $2.61 | 3.64 |
| 2025-06-30 | 12.74 | $2.79 | 4.57 |
| 2025-03-31 | 14.15 | $2.70 | 5.23 |
| 2024-12-31 | 16.97 | $2.38 | 7.13 |
| 2024-09-30 | 11.66 | $2.22 | 5.26 |
| 2024-06-30 | 6.17 | $2.08 | 2.97 |
| 2024-03-31 | 5.79 | $2.11 | 2.74 |
| 2023-12-31 | 5.71 | $2.12 | 2.69 |
| 2023-09-30 | 6.11 | $2.31 | 2.65 |
| 2023-06-30 | 3.88 | $2.75 | 1.41 |
| 2023-03-31 | 3.18 | $2.62 | 1.21 |
| 2022-12-31 | 3.27 | $2.51 | 1.30 |
| 2022-09-30 | 3.27 | $2.54 | 1.29 |
| 2022-06-30 | 3.76 | $2.52 | 1.49 |
| 2022-03-31 | 4.08 | $2.71 | 1.51 |
| 2021-12-31 | 5.42 | $2.71 | 2.00 |
| 2021-09-30 | 5.81 | $2.82 | 2.06 |
| 2021-06-30 | 6.31 | $2.70 | 2.33 |
| 2021-03-31 | 8.02 | $2.55 | 3.15 |
| 2020-12-31 | 8.00 | $2.51 | 3.19 |
| 2020-09-30 | 10.36 | $2.40 | 4.32 |
| 2020-06-30 | 11.60 | $2.32 | 4.99 |
| 2020-03-31 | 8.84 | $2.00 | 4.42 |
| 2019-12-31 | 13.39 | $2.04 | 6.58 |
| 2019-09-30 | 11.75 | $2.11 | 5.57 |
| 2019-06-30 | 11.14 | $1.93 | 5.78 |
| 2019-03-31 | 12.26 | $1.73 | 7.10 |
| 2018-12-31 | 11.32 | $1.47 | 7.68 |
| 2018-09-30 | 9.43 | $1.67 | 5.65 |
| 2018-06-30 | 5.47 | $1.56 | 3.50 |
| 2018-03-31 | 3.10 | $1.35 | 2.30 |
| 2017-12-31 | 4.08 | $1.16 | 3.52 |
| 2017-09-30 | 3.62 | $1.11 | 3.27 |
| 2017-06-30 | 3.72 | $1.02 | 3.64 |
| 2017-03-31 | 4.61 | $0.98 | 4.72 |
| 2016-12-31 | 6.99 | $1.03 | 6.77 |
| 2016-09-30 | 8.12 | $1.00 | 8.10 |
| 2016-06-30 | 11.67 | $0.76 | 15.37 |
| 2016-03-31 | 7.81 | $0.63 | 12.37 |
| 2015-12-31 | 8.17 | $0.50 | 16.31 |
| 2015-09-30 | 4.86 | $0.33 | 14.86 |
| 2015-06-30 | 3.18 | $0.24 | 13.36 |
| 2015-03-31 | 4.74 | $0.20 | 23.23 |
| 2014-12-31 | 7.81 | $0.32 | 24.25 |
| 2014-09-30 | 6.85 | $0.50 | 13.71 |
| 2014-06-30 | 8.65 | $0.27 | 31.64 |
| 2014-03-31 | 7.87 | $0.18 | 42.87 |
| 2013-12-31 | 9.91 | $-0.04 | -268.55 |
| 2013-09-30 | 14.29 | $2.09 | 6.85 |
| 2013-06-30 | 13.93 | $2.03 | 6.86 |
| 2013-03-31 | 14.11 | $2.15 | 6.57 |
| 2012-12-31 | 13.15 | $2.16 | 6.10 |
| 2012-09-30 | 20.60 | $2.12 | 9.74 |
| 2012-06-30 | 17.00 | $1.80 | 9.46 |
| 2012-03-31 | 22.58 | $1.44 | 15.64 |
| 2011-12-31 | 8.59 | $0.65 | 13.13 |
| 2011-09-30 | 9.01 | $-1.14 | -7.89 |
| 2011-06-30 | 9.01 | $-1.47 | -6.11 |
| 2011-03-31 | 4.26 | 0.00 | |
| 2010-12-31 | 2.34 | 0.00 | |
| 2010-09-30 | 3.00 | 0.00 | |
| 2010-06-30 | 3.06 | 0.00 | |
| 2010-03-31 | 2.34 | 0.00 | |
| 2009-12-31 | 1.50 | 0.00 | |
| 2009-09-30 | 2.31 | 0.00 | |
| 2009-06-30 | 4.02 | 0.00 | |
| 2009-03-31 | 4.65 | 0.00 | |
| 2008-12-31 | 1.20 | 0.00 | |
| 2008-09-30 | 1.20 | 0.00 | |
| 2008-06-30 | 1.50 | 0.00 | |
| 2008-03-31 | 1.41 | 0.00 | |
| 2007-12-31 | 1.20 | 0.00 | |
| 2007-09-30 | 1.32 | 0.00 | |
| 2007-06-30 | 1.44 | 0.00 | |
| 2007-03-31 | 2.04 | 0.00 | |
| 2006-12-31 | 2.64 | 0.00 | |
| 2006-09-30 | 4.44 | 0.00 | |
| 2006-06-30 | 5.10 | 0.00 | |
| 2006-03-31 | 13.51 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |